June 07, 2019
Article
Over a 6-year period, the analysis mapped out drugs cost patterns for the 49 top-selling brand-name medications in the United States based on pharmacy claims data from a health insurance database.
June 05, 2019
Article
Episodic cluster headaches represent 85% to 90% of cluster headache prevalence, with approximately 250,000 adults living with the condition in the United States.
April 19, 2019
Article
This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.
April 08, 2019
Article
To be eligible for dolutegravir and lamivudine, patients must have no history of antiretroviral therapy (ART) and no known or suspected substitutions associated with resistance to the individual components of the regimen.
March 31, 2019
Article
THE FDA has approved cladribine (Mavenclad, EMD Serono), a new oral treatment for relapsing forms of multiple sclerosis (MS) in adults including relapsing-remitting disease and active secondary progressive disease.
March 08, 2019
Article
Dupilumab (Dupixent, Regeneron and Sanofi) would be the first FDA-approved biologic for the treatment of severe chronic rhinosinusitis with nasal polyps.